Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-067293
Filing Date
2010-03-25
Accepted
2010-03-25 17:26:40
Documents
3
Period of Report
2009-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 63582
2 SECTION 302 CEO CERTIFICATION dex313.htm EX-31.3 8231
3 SECTION 302 CFO CERTIFICATION dex314.htm EX-31.4 8240
  Complete submission text file 0001193125-10-067293.txt   81820
Mailing Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 3084 DURHAM NC 27713 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1109
Type: 10-K/A | Act: 34 | File No.: 001-34600 | Film No.: 10705302
SIC: 8731 Services-Commercial Physical & Biological Research